ShoalFoods™ Calamari

In the waters of Argentina’s vast shoal region, sunlight reaches the entire ecosystem and modifies the Near-Surface Omega™ content of all marine organisms. This results in a calamari oil that naturally yields greater than 30 percent Omega 3 and provides a 15:12 DHA to EPA ratio. That means more brain-healthy DHA than other marine sources, and its naturally balanced with EPA. Other brands artificially boost their DHA levels. ShoalFoods™ provide more DHA in an unaltered, Whole Omega Nutrient form.*

This oceanic biome also recovers faster from fishing activity. We’re able to harvest omega-rich deep-sea fish in relatively shallow waters, and that means no harm to deep ocean environments.  It’s an Omega-3 that makes you feel good in every way.

Healthy Marine Ecosystem, Healthy YOU

Today, with modern diets imbalanced in Omega-6 consumption, everyone can benefit from Omega-3 supplementation. ShoalFoods™ Calamari is inherently optimal for brain health and many other benefits.*

Aquatic Omega-3 DHA and EPA are well researched for their effects throughout the body:

  • Maintain healthy cognitive function*
  • Promote healthy focus and concentration*
  • Support balanced mood*
  • Support cardiovascular health*
  • Maintain joint health and comfort*
  • Support a healthy immune system*
  • Promote healthy hormonal balance*

Pregnant and lactating women are often encouraged to supplement with Omega-3 DHA because it has been found to:

  • Promote healthy fetal neurological development*
  • Promote healthy birth weight*
  • Support healthy neurological development in breastfed infants*

Isn’t it time for Whole Omega Nutrients that naturally supply the DHA levels that you need?

Adolph S, Fuhrmann H, Schumann J. “Unsaturated fatty acids promote the phagocytosis of P. aeruginosa and R. equi by RAW264.7 macrophages.” Current Microbiology. 2012 Dec;65(6):649-55.

Ambrozova G, Pekarova M, Lojek A. “Effect of polyunsaturated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages.” The European Journal of Nutrition. 2010 Apr;49(3):133-9.

Chang CY, Ke DS, Chen JY. “Essential fatty acids and human brain.” Acta Neurologica Taiwan. 2009 Dec;18(4):231-41.

“FDA Announces Qualified Health Claims for Omega-3 Fatty Acids”. US Food & Drug Administration. Accessed August 27, 2015 at:

Fereidooni B, Jenabi E. “The use of omega 3 on pregnancy outcomes: a single-center study.” Journal of Pakistan Medical Association. 2014 Dec;64(12):1363-5.

Hawkey E, Nigg JT. “Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials.” Clinical Psychology Review. 2014 Aug;34(6):496-505.

Koletzko B, et. al. “Current information and Asian perspectives on long-chain polyunsaturated fatty acids in pregnancy, lactation, and infancy: systematic review and practice recommendations from an early nutrition academy workshop.” Annals of Nutrition and Metabolism. 2014;65(1):49-80.

Lee AL, Park Y. “The association between n-3 polyunsaturated fatty acid levels in erythrocytes and the risk of rheumatoid arthritis in Korean women.” Annals of Nutrition and Metabolism. 2013;63(1-2):88-95.

Leventakou V, et. al. “Fish intake during pregnancy, fetal growth, and gestational length in 19 European birth cohort studies.” The American Journal of Clinical Nutrition. 2014 Mar;99(3): 506-516.

McNamara RK, Strawn JR. “Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.” PharmaNutrition. 2013 Apr;1(2):41-49.

Molfino A, Gioia F, Fanelli FR, Muscaritoli M. “The Role for Dietary Omega-3 Fatty Acids Supplementation in Older Adults.” Nutrients. 2014 Oct;6(10):4058–4072.

Monahan KD, Feehan RP, Blaha C, McLaughlin DJ. “Effect of omega-3 polyunsaturated fatty acid supplementation on central arterial stiffness and arterial wave reflections in young and older healthy adults.” Physiological Reports. 2015 Jun; 3(6): e12438.

Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck SB. “Serum Phospholipid Docosahexaenonic Acid is Associated with Cognitive Functioning during Middle Adulthood.” The Journal of Nutrition. 2010 Apr;140(4):848–853.

Mullen A, Loscher CE, Roche HM. “Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages.” The Journal of Nutritional Biochemistry. 2010 May;21(5):444-50.

Norling LV, Perretti M. “The role of omega-3 derived resolvins in arthritis.” Current Opinion in Pharmacology. 2013 Jun;13(3):476-81.

Sohrabi N, Kashanian M, Ghafoori SS, Malakouti SK. “Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: a pilot trial.” Complementary Therapies in Medicine. 2013 Jun;21(3):141-6.

Tokuda H, Sueyasu T, Kontani M, Kwashima H, Shibata H, Koga Y. “Low Doses of Long-chain Polyunsaturated Fatty Acids Affect Cognitive Function in Elderly Japanese Men: A Randomized Controlled Trial.” Journal of Oleo Science. 2015;64(6):633-44.

Yurko-Mauro K, Alexander DD, Van Elswyk ME. “Docosahexaenoic acid and adult memory: a systematic review and meta-analysis.” PLoS One. 2015 Mar 18;10(3):e0120391. doi: 10.1371/journal.pone.0120391.

Zanetti M, et. al. “Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall.” BioMed Research International. 2015: 791978.